Recombinant antigen p30 (SAG1) for Toxoplasma gondii

Toxoplasma gondii

Major surface antigen p30 (SAG1) induces significant levels of p30 antibodies in all patients with toxoplasmosis. It has been described in the literature that this 30 kDa protein has the capacity to carry out the serological analysis of Toxoplasma infections.

Recombinant antigen for the diagnosis of Toxoplasmosis caused by Toxoplasma gondii, a human and animal infectious disease (mainly warm-blooded animals).

or
Name
p30 (SAG1)
Description
Major surface antigen
Gene
SAG1
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
SKU Source Applications In-house validation Details
RAG0011 E. coli WB, DB, IE, DE, CLIA, LF ELISA
WB		 Example of a certificate of analysis Material Safety Data Sheet
RAG0030 P. pastoris WB, DB, IE, DE, CLIA, LF Immunoassay blocker ELISA
WB		 Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Immunoassay blocker Due to the nonspecific interaction with anti-CCDs present in normal human or animal sera, we strongly recommend using our blocker SOR0001 on the analyzed sera in any immunoassay.
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format
Related proteins
ChimToxo1 p29 (GRA7) p35 (GRA8)

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Recombinant antigens for infectious diseases

How to reconsitute lyophizated vials

How to use the inmunoassay blocker for anti-cross-reactive carbohydrate determinants (CCD) antibodies

IVD reagents for diagnosis of Toxoplasmosis